Shibata Kiyosumi | Department Of Obstetrics And Gynecology Nagoya University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study
Placenta previa increta/percreta in Japan : A retrospective study of ultrasound findings, management and clinical course
Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo
IS-39 Expression of CD117, CD133, SALL4, OCT4, TCL1, and Glypican-3 (stem cell markers) in malignant germ cell tumors of the ovary(Group5 Oncology5,International Session)
Advances in treatment of epithelial ovarian cancer
The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells
Feasibility and effectiveness of postoperative adjuvant concurrent chemoradiation therapy in Japanese patients with high-risk early-stage cancer of the uterine cervix
LONG-TERM OUTCOME AND PROGNOSTIC FACTORS FOR YOLK SAC TUMOR OF THE OVARY
IS-20 Dipeptidyl peptidase IV/CD26 Expression in Endometrial Endometrioid Adenocarcinoma and Its Inverse Correlation with Tumor Grade
Identification and characterization of cancer stem cells in ovarian yolk sac tumors
Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery
Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma

もっと見る

スポンサーリンク